The Impact of Melatonin on Colon Cancer Cells’ Resistance to Doxorubicin in an in Vitro Study

MT1and MT2Melatonin Receptors: A Therapeutic Perspective

(2016) Jiabei Liu et al.   Annual Review of Pharmacology and Toxicology

Melatonin as an antioxidant: under promises but over delivers

(2016) Russel J. Reiter et al.   JOURNAL OF PINEAL RESEARCH

Melatonin and its receptor MT1 are involved in the downstream reaction to luteinizing hormone and participate in the regulation of luteinization in different species

(2016) Changjiu He et al.   JOURNAL OF PINEAL RESEARCH

Melatonin inhibits the Migration of Colon Cancer RKO cells by Down-regulating Myosin Light Chain Kinase Expression through Cross-talk with p38 MAPK

(2015) Duo-Bing Zou et al.   Asian Pacific Journal of Cancer Prevention

The organization of melatonin in lipid membranes

(2015) Hannah Dies et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Melatonin: an inhibitor of breast cancer

(2015) S. M. Hill et al.   ENDOCRINE-RELATED CANCER

Do Drugs Have Access to the P-Glycoprotein Drug-Binding Pocket through Gates?

(2015) Ricardo J. Ferreira et al.   Journal of Chemical Theory and Computation

Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal

(2015) Shulin Xiang et al.   JOURNAL OF PINEAL RESEARCH

Melatonin induces apoptosis of colorectal cancer cells through HDAC4 nuclear import mediated by CaMKII inactivation

(2015) Jia-Yi Wei et al.   JOURNAL OF PINEAL RESEARCH

RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D

(2014) Andrzej T. Slominski et al.   FASEB JOURNAL

Expression of the MT1 Melatonin Receptor in Ovarian Cancer Cells

(2014) Karolina Jablonska et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Melatonin reduces endothelin-1 expression and secretion in colon cancer cells through the inactivation of FoxO-1 and NF-κβ

(2014) Josefa León et al.   JOURNAL OF PINEAL RESEARCH

Melatonin Enhances the Anti-Tumor Effect of Fisetin by Inhibiting COX-2/iNOS and NF-κB/p300 Signaling Pathways

(2014) Canhui Yi et al.   PLoS One

Recent Advances in Protection against Doxorubicin-induced Toxicity

(2014) Rade Injac et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Melatonin MT1and MT2receptors display different molecular pharmacologies only in the G-protein coupled state

(2013) Céline Legros et al.   BRITISH JOURNAL OF PHARMACOLOGY

Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin

(2011) M. D. Mediavilla et al.   CURRENT MEDICINAL CHEMISTRY

Melatonin—A pleiotropic, orchestrating regulator molecule

(2010) Rüdiger Hardeland et al.   PROGRESS IN NEUROBIOLOGY